Search

Weight loss pills are 'unlikely to fix the obesity epidemic' in US, Health

5 (317) · $ 14.99 · In stock

Weight loss pills are 'unlikely to fix the obesity epidemic' in US, Health
Focus: As weight-loss drugs hit the U.S. market, doctors debate how to use  them

Focus: As weight-loss drugs hit the U.S. market, doctors debate how to use them

Weight loss drugs: 2024 expectations for Wegovy, Ozempic, Zepbound

Weight loss drugs: 2024 expectations for Wegovy, Ozempic, Zepbound

Obesity Drugs Won't Let The Food Industry Off The Hook

Obesity Drugs Won't Let The Food Industry Off The Hook

static01.nyt.com/images/2024/03/07/autossell/NYT_O

static01.nyt.com/images/2024/03/07/autossell/NYT_O

Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups

Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups

A new 'miracle' weight-loss drug really works — raising huge questions

A new 'miracle' weight-loss drug really works — raising huge questions

Wegovy weight-loss drug really works but there's a catch

Wegovy weight-loss drug really works but there's a catch

Real-world costs of obesity-related complications over eight years: a US  retrospective cohort study in 28,500 individuals

Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals

The Health Risks of Fad Diets

The Health Risks of Fad Diets

Obesity In The United States Is At Epidemic Levels

Obesity In The United States Is At Epidemic Levels

Pediatricians Recommend Weight-Loss Drugs for Obese Children - WSJ

Pediatricians Recommend Weight-Loss Drugs for Obese Children - WSJ

Men's Health and the Issue of Obesity

Men's Health and the Issue of Obesity

Weight loss pills are 'unlikely to fix the obesity epidemic' in US, Health

Weight loss pills are 'unlikely to fix the obesity epidemic' in US, Health

Nutrition: Major Government Fail?

Nutrition: Major Government Fail?

Ozempic, Wegovy and beyond: Could the next wave of weight-loss drugs end  obesity?

Ozempic, Wegovy and beyond: Could the next wave of weight-loss drugs end obesity?